Chemistry and Physics of Lipids
ISSN 0009-3084 · Elsevier BV · Ireland · active 1927–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Chemistry and Physics of Lipids a predatory journal?
Our screening does not flag Chemistry and Physics of Lipids. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Chemistry and Physics of Lipids indexed in Scopus or Web of Science?
Per our venue index, Chemistry and Physics of Lipids appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Chemistry and Physics of Lipids's impact?
Papers in Chemistry and Physics of Lipids are cited about 2.1 times each within two years of publication, and Scimago places it in Q2, with an h-index of 158. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Chemistry and Physics of Lipids open access?
We hold no reliable open-access classification for Chemistry and Physics of Lipids. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Progress in Lipid ResearchQ1 · Elsevier BV
- Cellular & Molecular Biology LettersQ1 · BioMed Central
- Current Atherosclerosis ReportsQ1 · Springer Science+Business Media
- Prostate Cancer and Prostatic DiseasesQ1 · Springer Nature
- Colloids and Surfaces B BiointerfacesQ1 · Elsevier BV
- Current Opinion in LipidologyQ1 · Lippincott Williams & Wilkins